Biomel
Seedtable Score
37
Startups
1
Funding Rounds
1
Investors
$6m
Money raised
Overview
Biomel holds strong potential due to its innovative focus on plant-based gut health products. Operating from London on a direct-to-consumer model, the company caters to individuals seeking healthier and more natural options. Supported by investors like IRIS, Biomel distinguishes itself in a competitive market by offering an alternative to traditional probiotic supplements. Its emphasis on plant-based ingredients appeals to health-conscious consumers with digestive issues or poor gut health. This unique positioning could help Biomel capture a niche yet growing segment within the broader health and wellness market.
- Website: https://biomel.life
- Business model: b2c
- Company size: 11 - 51 employees
- Headquarters: London, UK
- Founded: 2017
- Social accounts: Linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Biomel has raised a total of $6m in funding over 1 rounds.
Key Insights:
- Seed: $6m
Biomel Seed (2023, $5M)
$6m